Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 71 entries
Sorted by: Best Match Show Resources per page
Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report.

Experimental hematology & oncology

Tedesco S, Postacchini L, Manfredi L, Goteri G, Luchetti MM, Festa A, Gabrielli A, Pomponio G.
PMID: 25671135
Exp Hematol Oncol. 2015 Jan 14;4(1):3. doi: 10.1186/2162-3619-4-3. eCollection 2015.

BACKGROUND: Castleman-Kojima disease (TAFRO Syndrome) is characterized by Thrombocytopenia, Anasarca, myeloFibrosis, Renal dysfunction, Organomegaly, multiple lymphadenopathy and histopathology pattern of atypical Castleman's disease (CD). Only few cases of this recently identified unique variant of Multicentric CD (MCD) are described...

Cite
Tedesco S, Postacchini L, Manfredi L, et al. Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report. Exp Hematol Oncol. 2015;4(1):3doi: 10.1186/2162-3619-4-3.
Tedesco, S., Postacchini, L., Manfredi, L., Goteri, G., Luchetti, M. M., Festa, A., Gabrielli, A., & Pomponio, G. (2015). Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report. Experimental hematology & oncology, 4(1), 3. https://doi.org/10.1186/2162-3619-4-3
Tedesco, Silvia, et al. "Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report." Experimental hematology & oncology vol. 4,1 (2015): 3. doi: https://doi.org/10.1186/2162-3619-4-3
Tedesco S, Postacchini L, Manfredi L, Goteri G, Luchetti MM, Festa A, Gabrielli A, Pomponio G. Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report. Exp Hematol Oncol. 2015 Jan 14;4(1):3. doi: 10.1186/2162-3619-4-3. eCollection 2015. PMID: 25671135; PMCID: PMC4322808.
Copy Download .nbib Format: NLM
Correction to: Gastrointestinal juvenile-like (inflammatory/hyperplastic) mucosal polyps in neurofibromatosis type 1 with no concurrent genetic or clinical evidence of other syndromes.

Virchows Archiv : an international journal of pathology

Ravegnini G, Quero G, Sammarini G, Giustiniani MC, Castri F, Pomponi MG, Angelini S, Alfieri S, Genuardi M, Zamboni G, Ricci R.
PMID: 30306267
Virchows Arch. 2019 Feb;474(2):265. doi: 10.1007/s00428-018-2472-4.

The authors regret that the original version of this article, unfortunately, contained an error. The values "1/3 (33%)" reported in the second to last sentence of the Discussion are wrong; the correct values are "2/2 (100%)". These are presented...

Cite
Ravegnini G, Quero G, Sammarini G, et al. Correction to: Gastrointestinal juvenile-like (inflammatory/hyperplastic) mucosal polyps in neurofibromatosis type 1 with no concurrent genetic or clinical evidence of other syndromes. Virchows Arch. 2019;474(2):265doi: 10.1007/s00428-018-2472-4.
Ravegnini, G., Quero, G., Sammarini, G., Giustiniani, M. C., Castri, F., Pomponi, M. G., Angelini, S., Alfieri, S., Genuardi, M., Zamboni, G., & Ricci, R. (2019). Correction to: Gastrointestinal juvenile-like (inflammatory/hyperplastic) mucosal polyps in neurofibromatosis type 1 with no concurrent genetic or clinical evidence of other syndromes. Virchows Archiv : an international journal of pathology, 474(2), 265. https://doi.org/10.1007/s00428-018-2472-4
Ravegnini, Gloria, et al. "Correction to: Gastrointestinal juvenile-like (inflammatory/hyperplastic) mucosal polyps in neurofibromatosis type 1 with no concurrent genetic or clinical evidence of other syndromes." Virchows Archiv : an international journal of pathology vol. 474,2 (2019): 265. doi: https://doi.org/10.1007/s00428-018-2472-4
Ravegnini G, Quero G, Sammarini G, Giustiniani MC, Castri F, Pomponi MG, Angelini S, Alfieri S, Genuardi M, Zamboni G, Ricci R. Correction to: Gastrointestinal juvenile-like (inflammatory/hyperplastic) mucosal polyps in neurofibromatosis type 1 with no concurrent genetic or clinical evidence of other syndromes. Virchows Arch. 2019 Feb;474(2):265. doi: 10.1007/s00428-018-2472-4. PMID: 30306267.
Copy Download .nbib Format: NLM
Corrigendum to "Music tuned to 440 hz versus 432 hz and the health effects: a double-blind cross-over pilot study" [Explore Journal Vol. 15 (2019) 283-290/ No. 4].

Explore (New York, N.Y.)

Calamassi D, Pomponi GP.
PMID: 32113613
Explore (NY). 2020 Jan - Feb;16(1):8. doi: 10.1016/j.explore.2020.01.001.

No abstract available.

Cite
Calamassi D, Pomponi GP. Corrigendum to "Music tuned to 440 hz versus 432 hz and the health effects: a double-blind cross-over pilot study" [Explore Journal Vol. 15 (2019) 283-290/ No. 4]. Explore (NY). 2020;16(1):8doi: 10.1016/j.explore.2020.01.001.
Calamassi, D., & Pomponi, G. P. (2020). Corrigendum to "Music tuned to 440 hz versus 432 hz and the health effects: a double-blind cross-over pilot study" [Explore Journal Vol. 15 (2019) 283-290/ No. 4]. Explore (New York, N.Y.), 16(1), 8. https://doi.org/10.1016/j.explore.2020.01.001
Calamassi, Diletta, and Pomponi, Gian Paolo. "Corrigendum to "Music tuned to 440 hz versus 432 hz and the health effects: a double-blind cross-over pilot study" [Explore Journal Vol. 15 (2019) 283-290/ No. 4]." Explore (New York, N.Y.) vol. 16,1 (2020): 8. doi: https://doi.org/10.1016/j.explore.2020.01.001
Calamassi D, Pomponi GP. Corrigendum to "Music tuned to 440 hz versus 432 hz and the health effects: a double-blind cross-over pilot study" [Explore Journal Vol. 15 (2019) 283-290/ No. 4]. Explore (NY). 2020 Jan - Feb;16(1):8. doi: 10.1016/j.explore.2020.01.001. PMID: 32113613.
Copy Download .nbib Format: NLM
The Importance of Heart Team in Minimally Invasive Direct Coronary Artery Bypass.

The Annals of thoracic surgery

Mastroiacovo G, Pirola S, Pompilio G.
PMID: 33794155
Ann Thorac Surg. 2021 Mar 29; doi: 10.1016/j.athoracsur.2021.03.057. Epub 2021 Mar 29.

No abstract available.

Cite
Mastroiacovo G, Pirola S, Pompilio G. The Importance of Heart Team in Minimally Invasive Direct Coronary Artery Bypass. Ann Thorac Surg. 2021;doi: 10.1016/j.athoracsur.2021.03.057.
Mastroiacovo, G., Pirola, S., & Pompilio, G. (2021). The Importance of Heart Team in Minimally Invasive Direct Coronary Artery Bypass. The Annals of thoracic surgery, . https://doi.org/10.1016/j.athoracsur.2021.03.057
Mastroiacovo, Giorgio, et al. "The Importance of Heart Team in Minimally Invasive Direct Coronary Artery Bypass." The Annals of thoracic surgery vol. (2021). doi: https://doi.org/10.1016/j.athoracsur.2021.03.057
Mastroiacovo G, Pirola S, Pompilio G. The Importance of Heart Team in Minimally Invasive Direct Coronary Artery Bypass. Ann Thorac Surg. 2021 Mar 29; doi: 10.1016/j.athoracsur.2021.03.057. Epub 2021 Mar 29. PMID: 33794155.
Copy Download .nbib Format: NLM
A Circular Economy: Where Will It Take Us?.

Circular economy and sustainability

Hart J, Pomponi F.
PMID: 34888551
Circ Econ Sustain. 2021 Mar 09;1-15. doi: 10.1007/s43615-021-00013-4. Epub 2021 Mar 09.

The avalanche of environmental challenges, from local to global and back, has prompted responses at all levels from personal to inter-governmental. The results of these responses have fallen in the range between useful and counterproductive, with many examples on...

Cite
Hart J, Pomponi F. A Circular Economy: Where Will It Take Us?. Circ Econ Sustain. 2021;1-15doi: 10.1007/s43615-021-00013-4.
Hart, J., & Pomponi, F. (2021). A Circular Economy: Where Will It Take Us?. Circular economy and sustainability, 1-15. https://doi.org/10.1007/s43615-021-00013-4
Hart, Jim, and Pomponi, Francesco. "A Circular Economy: Where Will It Take Us?." Circular economy and sustainability vol. (2021): 1-15. doi: https://doi.org/10.1007/s43615-021-00013-4
Hart J, Pomponi F. A Circular Economy: Where Will It Take Us?. Circ Econ Sustain. 2021 Mar 09;1-15. doi: 10.1007/s43615-021-00013-4. Epub 2021 Mar 09. PMID: 34888551; PMCID: PMC7941867.
Copy Download .nbib Format: NLM
Co-Occurrence of Fragile X Syndrome with a Second Genetic Condition: Three Independent Cases of Double Diagnosis.

Genes

Tabolacci E, Pomponi MG, Remondini L, Pietrobono R, Orteschi D, Nobile V, Pucci C, Musto E, Pane M, Mercuri EM, Neri G, Genuardi M, Chiurazzi P, Zollino M.
PMID: 34946857
Genes (Basel). 2021 Nov 27;12(12). doi: 10.3390/genes12121909.

Fragile X syndrome (FXS) is the most common form of inherited intellectual disability and autism caused by the instability of a CGG trinucleotide repeat in exon 1 of the

Cite
Tabolacci E, Pomponi MG, Remondini L, et al. Co-Occurrence of Fragile X Syndrome with a Second Genetic Condition: Three Independent Cases of Double Diagnosis. Genes (Basel). 2021;12(12)doi: 10.3390/genes12121909.
Tabolacci, E., Pomponi, M. G., Remondini, L., Pietrobono, R., Orteschi, D., Nobile, V., Pucci, C., Musto, E., Pane, M., Mercuri, E. M., Neri, G., Genuardi, M., Chiurazzi, P., & Zollino, M. (2021). Co-Occurrence of Fragile X Syndrome with a Second Genetic Condition: Three Independent Cases of Double Diagnosis. Genes, 12(12), . https://doi.org/10.3390/genes12121909
Tabolacci, Elisabetta, et al. "Co-Occurrence of Fragile X Syndrome with a Second Genetic Condition: Three Independent Cases of Double Diagnosis." Genes vol. 12,12 (2021). doi: https://doi.org/10.3390/genes12121909
Tabolacci E, Pomponi MG, Remondini L, Pietrobono R, Orteschi D, Nobile V, Pucci C, Musto E, Pane M, Mercuri EM, Neri G, Genuardi M, Chiurazzi P, Zollino M. Co-Occurrence of Fragile X Syndrome with a Second Genetic Condition: Three Independent Cases of Double Diagnosis. Genes (Basel). 2021 Nov 27;12(12). doi: 10.3390/genes12121909. PMID: 34946857.
Copy Download .nbib Format: NLM
The usefulness of cardiac CT integrated with FFRCT for planning myocardial revascularization in complex coronary artery disease: a lesson from SYNTAX studies.

Cardiovascular diagnosis and therapy

Andreini D, Mushtaq S, Conte E, Mei M, Nicoli F, Melotti E, Pompilio G, Pepi M, Bartorelli AL, Onuma Y, Serruys PW.
PMID: 33381442
Cardiovasc Diagn Ther. 2020 Dec;10(6):2036-2047. doi: 10.21037/cdt.2019.11.07.

After two decades of clinical use, during which coronary CT angiography (CCTA) was considered an appropriate method for the non-invasive assessment of patients with suspected stable coronary artery disease (CAD) and low-to-intermediate pretest likelihood of CAD, a growing body...

Cite
Andreini D, Mushtaq S, Conte E, et al. The usefulness of cardiac CT integrated with FFRCT for planning myocardial revascularization in complex coronary artery disease: a lesson from SYNTAX studies. Cardiovasc Diagn Ther. 2020;10(6):2036-2047doi: 10.21037/cdt.2019.11.07.
Andreini, D., Mushtaq, S., Conte, E., Mei, M., Nicoli, F., Melotti, E., Pompilio, G., Pepi, M., Bartorelli, A. L., Onuma, Y., & Serruys, P. W. (2020). The usefulness of cardiac CT integrated with FFRCT for planning myocardial revascularization in complex coronary artery disease: a lesson from SYNTAX studies. Cardiovascular diagnosis and therapy, 10(6), 2036-2047. https://doi.org/10.21037/cdt.2019.11.07
Andreini, Daniele, et al. "The usefulness of cardiac CT integrated with FFRCT for planning myocardial revascularization in complex coronary artery disease: a lesson from SYNTAX studies." Cardiovascular diagnosis and therapy vol. 10,6 (2020): 2036-2047. doi: https://doi.org/10.21037/cdt.2019.11.07
Andreini D, Mushtaq S, Conte E, Mei M, Nicoli F, Melotti E, Pompilio G, Pepi M, Bartorelli AL, Onuma Y, Serruys PW. The usefulness of cardiac CT integrated with FFRCT for planning myocardial revascularization in complex coronary artery disease: a lesson from SYNTAX studies. Cardiovasc Diagn Ther. 2020 Dec;10(6):2036-2047. doi: 10.21037/cdt.2019.11.07. PMID: 33381442; PMCID: PMC7758756.
Copy Download .nbib Format: NLM
Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease.

Neurobiology of aging

Charissé D, Erus G, Pomponio R, Gorges M, Schmidt N, Schneider C, Liepelt-Scarfone I, Riedel O, Reetz K, Schulz JB, Berg D, Storch A, Witt K, Dodel R, Kalbe E, Kassubek J, Hilker-Roggendorf R, Baudrexel S.
PMID: 34649002
Neurobiol Aging. 2021 Sep 06;109:31-42. doi: 10.1016/j.neurobiolaging.2021.08.020. Epub 2021 Sep 06.

Recently, it was shown that patients with Parkinson's disease (PD) who exhibit an "Alzheimer's disease (AD)-like" pattern of brain atrophy are at greater risk for future cognitive decline. This study aimed to investigate whether this association is domain-specific and...

Cite
Charissé D, Erus G, Pomponio R, et al. Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease. Neurobiol Aging. 2021;109:31-42doi: 10.1016/j.neurobiolaging.2021.08.020.
Charissé, D., Erus, G., Pomponio, R., Gorges, M., Schmidt, N., Schneider, C., Liepelt-Scarfone, I., Riedel, O., Reetz, K., Schulz, J. B., Berg, D., Storch, A., Witt, K., Dodel, R., Kalbe, E., Kassubek, J., Hilker-Roggendorf, R., & Baudrexel, S. (2021). Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease. Neurobiology of aging, 10931-42. https://doi.org/10.1016/j.neurobiolaging.2021.08.020
Charissé, Daniel, et al. "Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease." Neurobiology of aging vol. 109 (2021): 31-42. doi: https://doi.org/10.1016/j.neurobiolaging.2021.08.020
Charissé D, Erus G, Pomponio R, Gorges M, Schmidt N, Schneider C, Liepelt-Scarfone I, Riedel O, Reetz K, Schulz JB, Berg D, Storch A, Witt K, Dodel R, Kalbe E, Kassubek J, Hilker-Roggendorf R, Baudrexel S. Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease. Neurobiol Aging. 2021 Sep 06;109:31-42. doi: 10.1016/j.neurobiolaging.2021.08.020. Epub 2021 Sep 06. PMID: 34649002.
Copy Download .nbib Format: NLM
Evaluation of SuperCAZ/AVI® Medium for Screening Ceftazidime-avibactam Resistant Gram-negative Isolates.

Diagnostic microbiology and infectious disease

Sadek M, Poirel L, Dominguez Pino M, D'Emidio F, Pomponio S, Nordmann P.
PMID: 34419742
Diagn Microbiol Infect Dis. 2021 Dec;101(4):115475. doi: 10.1016/j.diagmicrobio.2021.115475. Epub 2021 Jul 01.

The industrial version of SuperCAZ/AVI® medium developed for screening CAZ/AVI resistant Gram-negative isolates has been evaluated here using a collection of 87 well-characterized clinical isolates of worldwide origin. In addition, testing was performed by spiking stools with a series...

Cite
Sadek M, Poirel L, Dominguez Pino M, et al. Evaluation of SuperCAZ/AVI® Medium for Screening Ceftazidime-avibactam Resistant Gram-negative Isolates. Diagn Microbiol Infect Dis. 2021;101(4):115475doi: 10.1016/j.diagmicrobio.2021.115475.
Sadek, M., Poirel, L., Dominguez Pino, M., D'Emidio, F., Pomponio, S., & Nordmann, P. (2021). Evaluation of SuperCAZ/AVI® Medium for Screening Ceftazidime-avibactam Resistant Gram-negative Isolates. Diagnostic microbiology and infectious disease, 101(4), 115475. https://doi.org/10.1016/j.diagmicrobio.2021.115475
Sadek, Mustafa, et al. "Evaluation of SuperCAZ/AVI® Medium for Screening Ceftazidime-avibactam Resistant Gram-negative Isolates." Diagnostic microbiology and infectious disease vol. 101,4 (2021): 115475. doi: https://doi.org/10.1016/j.diagmicrobio.2021.115475
Sadek M, Poirel L, Dominguez Pino M, D'Emidio F, Pomponio S, Nordmann P. Evaluation of SuperCAZ/AVI® Medium for Screening Ceftazidime-avibactam Resistant Gram-negative Isolates. Diagn Microbiol Infect Dis. 2021 Dec;101(4):115475. doi: 10.1016/j.diagmicrobio.2021.115475. Epub 2021 Jul 01. PMID: 34419742.
Copy Download .nbib Format: NLM
Evidence of SARS-CoV-2 Transcriptional Activity in Cardiomyocytes of COVID-19 Patients without Clinical Signs of Cardiac Involvement.

Biomedicines

Bulfamante GP, Perrucci GL, Falleni M, Sommariva E, Tosi D, Martinelli C, Songia P, Poggio P, Carugo S, Pompilio G.
PMID: 33352880
Biomedicines. 2020 Dec 18;8(12). doi: 10.3390/biomedicines8120626.

AIMS: A considerable proportion of patients affected by coronavirus respiratory disease (COVID-19) develop cardiac injury. The viral impact in cardiomyocytes deserves, however, further investigations, especially in asymptomatic patients.METHODS: We investigated for SARS-CoV-2 presence and activity in heart tissues of...

Cite
Bulfamante GP, Perrucci GL, Falleni M, et al. Evidence of SARS-CoV-2 Transcriptional Activity in Cardiomyocytes of COVID-19 Patients without Clinical Signs of Cardiac Involvement. Biomedicines. 2020;8(12)doi: 10.3390/biomedicines8120626.
Bulfamante, G. P., Perrucci, G. L., Falleni, M., Sommariva, E., Tosi, D., Martinelli, C., Songia, P., Poggio, P., Carugo, S., & Pompilio, G. (2020). Evidence of SARS-CoV-2 Transcriptional Activity in Cardiomyocytes of COVID-19 Patients without Clinical Signs of Cardiac Involvement. Biomedicines, 8(12), . https://doi.org/10.3390/biomedicines8120626
Bulfamante, Gaetano Pietro, et al. "Evidence of SARS-CoV-2 Transcriptional Activity in Cardiomyocytes of COVID-19 Patients without Clinical Signs of Cardiac Involvement." Biomedicines vol. 8,12 (2020). doi: https://doi.org/10.3390/biomedicines8120626
Bulfamante GP, Perrucci GL, Falleni M, Sommariva E, Tosi D, Martinelli C, Songia P, Poggio P, Carugo S, Pompilio G. Evidence of SARS-CoV-2 Transcriptional Activity in Cardiomyocytes of COVID-19 Patients without Clinical Signs of Cardiac Involvement. Biomedicines. 2020 Dec 18;8(12). doi: 10.3390/biomedicines8120626. PMID: 33352880; PMCID: PMC7767122.
Copy Download .nbib Format: NLM
Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease.

Neurobiology of aging

Charissé D, Erus G, Pomponio R, Gorges M, Schmidt N, Schneider C, Liepelt-Scarfone I, Riedel O, Reetz K, Schulz JB, Berg D, Storch A, Witt K, Dodel R, Kalbe E, Kassubek J, Hilker-Roggendorf R, Baudrexel S.
PMID: 34649002
Neurobiol Aging. 2022 Jan;109:31-42. doi: 10.1016/j.neurobiolaging.2021.08.020. Epub 2021 Sep 06.

Recently, it was shown that patients with Parkinson's disease (PD) who exhibit an "Alzheimer's disease (AD)-like" pattern of brain atrophy are at greater risk for future cognitive decline. This study aimed to investigate whether this association is domain-specific and...

Cite
Charissé D, Erus G, Pomponio R, et al. Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease. Neurobiol Aging. 2021;109:31-42doi: 10.1016/j.neurobiolaging.2021.08.020.
Charissé, D., Erus, G., Pomponio, R., Gorges, M., Schmidt, N., Schneider, C., Liepelt-Scarfone, I., Riedel, O., Reetz, K., Schulz, J. B., Berg, D., Storch, A., Witt, K., Dodel, R., Kalbe, E., Kassubek, J., Hilker-Roggendorf, R., & Baudrexel, S. (2022). Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease. Neurobiology of aging, 10931-42. https://doi.org/10.1016/j.neurobiolaging.2021.08.020
Charissé, Daniel, et al. "Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease." Neurobiology of aging vol. 109 (2022): 31-42. doi: https://doi.org/10.1016/j.neurobiolaging.2021.08.020
Charissé D, Erus G, Pomponio R, Gorges M, Schmidt N, Schneider C, Liepelt-Scarfone I, Riedel O, Reetz K, Schulz JB, Berg D, Storch A, Witt K, Dodel R, Kalbe E, Kassubek J, Hilker-Roggendorf R, Baudrexel S. Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease. Neurobiol Aging. 2022 Jan;109:31-42. doi: 10.1016/j.neurobiolaging.2021.08.020. Epub 2021 Sep 06. PMID: 34649002.
Copy Download .nbib Format: NLM
Understanding secondary overtriage for neurosurgical patients in a rural tertiary care setting.

Clinical neurology and neurosurgery

Kanter JH, Pomponio MK, Khan I, Hong J.
PMID: 34959106
Clin Neurol Neurosurg. 2021 Dec 23;213:107101. doi: 10.1016/j.clineuro.2021.107101. Epub 2021 Dec 23.

OBJECTIVE: Excessive interfacility transfer to a tertiary care facility of minimally injured patients for subspecialty evaluation leads to overuse of resources and is referred to as secondary overtriage (SO). Little is known regarding the epidemiology of SO in rural...

Cite
Kanter JH, Pomponio MK, Khan I, et al. Understanding secondary overtriage for neurosurgical patients in a rural tertiary care setting. Clin Neurol Neurosurg. 2021;213:107101doi: 10.1016/j.clineuro.2021.107101.
Kanter, J. H., Pomponio, M. K., Khan, I., & Hong, J. (2021). Understanding secondary overtriage for neurosurgical patients in a rural tertiary care setting. Clinical neurology and neurosurgery, 213107101. https://doi.org/10.1016/j.clineuro.2021.107101
Kanter, John H, et al. "Understanding secondary overtriage for neurosurgical patients in a rural tertiary care setting." Clinical neurology and neurosurgery vol. 213 (2021): 107101. doi: https://doi.org/10.1016/j.clineuro.2021.107101
Kanter JH, Pomponio MK, Khan I, Hong J. Understanding secondary overtriage for neurosurgical patients in a rural tertiary care setting. Clin Neurol Neurosurg. 2021 Dec 23;213:107101. doi: 10.1016/j.clineuro.2021.107101. Epub 2021 Dec 23. PMID: 34959106.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 71 entries